Candel Therapeutics, Inc. (CADL)
11.31
-0.86
(-7.07%)
USD |
NASDAQ |
Sep 10, 14:42
Candel Therapeutics Net Income (Quarterly) : -38.90M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -38.90M |
| March 31, 2026 | -8.861M |
| December 31, 2025 | -29.50M |
| September 30, 2025 | -11.27M |
| June 30, 2025 | -4.796M |
| March 31, 2025 | 7.379M |
| December 31, 2024 | -14.07M |
| September 30, 2024 | -10.65M |
| June 30, 2024 | -22.24M |
| March 31, 2024 | -8.221M |
| December 31, 2023 | -11.10M |
| September 30, 2023 | -8.435M |
| June 30, 2023 | -9.614M |
| Date | Value |
|---|---|
| March 31, 2023 | -8.795M |
| December 31, 2022 | -5.083M |
| September 30, 2022 | -8.688M |
| June 30, 2022 | -4.149M |
| March 31, 2022 | -0.874M |
| December 31, 2021 | 1.596M |
| September 30, 2021 | -16.16M |
| June 30, 2021 | -17.08M |
| March 31, 2021 | -4.478M |
| December 31, 2020 | -10.48M |
| September 30, 2020 | -2.554M |
| June 30, 2020 | -2.876M |
| March 31, 2020 | -1.772M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 38.90M |
| EPS Diluted (Quarterly) | -0.5248 |
| Enterprise Value | 774.31M |
| Earnings Yield | -12.46% |
| Normalized Earnings Yield | -10.80 |